
|Articles|January 1, 2004
Adjustability a plus for microkeratomes
Author(s)Lynda Charters
Tampere, Finland-Both the M2 Single Use microkeratome and the M2 microkeratome with the new 90-?m head (Moria, Antony, France) have been performing well in clinical trials.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Development of maculopathy associated with systemic medications
2
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
3
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
4
Evolving glaucoma therapy: A new era of interventional strategies
5

















































.png)


